Cyprus vs Poland: Statin use vs. average non-HDL cholesterol levels
Cyprus
3.5
in 2018
Poland
3.5
in 2018
Cyprus rank
52nd
Poland rank
52nd
Statin use vs. average non-HDL cholesterol levels over time
- Cyprus
- Poland
How they compare
Cyprus currently reports 3.5 against 3.5 in Poland, a difference of 0.
The two have swapped places 5 times across 39 shared years of data; in 1980 it was Cyprus ahead.
Cyprus ranks 52nd and Poland ranks 52nd of 191 countries.
Across the 4 decades both report, Cyprus averaged higher in 3 and Poland in 1.
Head to head by decade
| Decade | Cyprus | Poland | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4.2 | 3.9 | 0.3 | Cyprus |
| 1990s | 4.04 | 3.9 | 0.14 | Cyprus |
| 2000s | 3.79 | 3.8 | 0.01 | Poland |
| 2010s | 3.62 | 3.59 | 0.0333 | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Cyprus or Poland?
- Cyprus, at 3.5 against 3.5 in Poland as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Cyprus and Poland?
- 0, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Poland?
- 39 years are reported by both, from 1980 to 2018.
- How do Cyprus and Poland rank globally for statin use vs. average non-hdl cholesterol levels?
- Cyprus ranks 52nd and Poland ranks 52nd of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.